SCHEMBL30745220

SCHEMBL30745220

O=C(Nc1ccc(F)cc1F)C(NC(=S)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1ccccc1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ULK1 O75385 2/20 0.85
MAPT P10636 5/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
TACR1 P25103 3/20 0.50
SMN1; SMN2 Q16637 4/20 0.47
HTT P42858 2/20 0.47
LMNA P02545 1/20 0.47
TP53 P04637 1/20 0.47
XBP1 P17861 1/20 0.47
S1PR3 Q99500 1/20 0.47
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
ACP1 P24666 1/20 0.46
PTPN7 P35236 1/20 0.46
PTPN12 Q05209 1/20 0.46
PTPN13 Q12923 1/20 0.46
SSU72 Q9NP77 1/20 0.46
KDM4E B2RXH2 3/20 0.43
ALDH1A1 P00352 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20418419 1.00 ULK1 (0.85) ULK1MAPTMEN1KMT2ATACR1
SCHEMBL29520034 1.00 ULK1 (0.85) ULK1MAPTMEN1KMT2ATACR1
SCHEMBL31252452 0.80 ULK1 (0.56) ULK1MAPTKMT2ATACR1SMN1; SMN2
SCHEMBL6719158 0.76 ULK1 (0.61) ULK1MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL31252380 0.74 POLB (0.49) ULK1KMT2ASMN1; SMN2HTTNPC1
SCHEMBL31252496 0.74 POLB (0.49) ULK1KMT2ASMN1; SMN2HTTNPC1
SCHEMBL20418676 0.73 ULK1 (0.56) ULK1MAPTKMT2ASMN1; SMN2HTT
SCHEMBL20418423 0.73 ULK1 (0.56) ULK1MAPTKMT2ASMN1; SMN2HTT
SCHEMBL6718043 0.72 ULK1 (0.56) ULK1MAPTMEN1KMT2AHTT
SCHEMBL6715842 0.72 ULK1 (0.55) ULK1MAPTMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240000753-A1 METHODS AND COMPOSITIONS TO INCREASE LIFESPAN AND HEALTHSPAN BY MIMICKING THE EFFECTS OF TIME-RESTRICTED FEEDING THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2024-01-04 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240000753-A1 METHODS AND COMPOSITIONS TO INCREASE LIFESPAN AND HEALTHSPAN BY MIMICKING THE EFFECTS OF TIME-RESTRICTED FEEDING ULK1, ULK2, RPS6KA3 ULK1 1/4885MAPT 583/4885MEN1 3614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.